Chylothorax Therapy
Somatostatin and octreotide are beneficial for children with chylothorax
Published in Gastroenterology Week, June 19th, 2006
According to recent research published in the journal Intensive Care Medicine, "Chylothorax is a rare but life-threatening condition in children. To date, there is no commonly accepted treatment protocol. Somatostatin and octreotide have recently been used for treating chylothorax in children. We set out to summarize the evidence on the efficacy and safety of somatostatin and octreotide in treating young children with chylothorax."
"A systematic literature search (Cochrane Library, EMBASE and PubMed databases) and literature hand search of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gastroenterology Week
More Articles from Gastroenterology Week
- Abdominal Cramping
Evidence validates global prevalence and severity of abdominal cramping and pain - Acid Reflux
Study shows erosive esophagitis healing linked to gastric acid control - Colorectal Cancer
Geriatric colorectal cancer treated by capecitabine plus oxaliplatin - Gastrointestinal Stromal Tumors
Gastrointestinal stromal tumor associated with new mutation in KIT exon 9 - Obesity & Cancer
Gastric and esophageal adenocarcinoma risk increased with increased BMI - Allergy Medicine
Probiotics have role in management of allergic disease - More from this issue of Gastroenterology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
